Sort by

Send to:

Choose Destination

Search results

Items: 5


Endocine™, N3OA and N3OASq; three mucosal adjuvants that enhance the immune response to nasal influenza vaccination.

Falkeborn T, Bråve A, Larsson M, Akerlind B, Schröder U, Hinkula J.

PLoS One. 2013 Aug 8;8(8):e70527. doi: 10.1371/journal.pone.0070527. eCollection 2013.


DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.

Nyström S, Bråve A, Falkeborn T, Devito C, Rissiek B, Johansson DX, Schröder U, Uematsu S, Akira S, Hinkula J, Applequist SE.

Vaccines (Basel). 2013 Sep 25;1(4):415-43. doi: 10.3390/vaccines1040415.


A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro.

Chang CH, Hinkula J, Loo M, Falkeborn T, Li R, Cardillo TM, Rossi EA, Goldenberg DM, Wahren B.

PLoS One. 2012;7(7):e41235. doi: 10.1371/journal.pone.0041235. Epub 2012 Jul 23.


Limited effect on NS3-NS4A protein cleavage after alanine substitutions within the immunodominant HLA-A2-restricted epitope of the hepatitis C virus genotype 3a non-structural 3/4A protease.

Ahlén G, Chen A, Roe B, Falkeborn T, Frelin L, Hall WW, Sällberg M, Söderholm J.

J Gen Virol. 2012 Aug;93(Pt 8):1680-6. doi: 10.1099/vir.0.043745-0. Epub 2012 May 16.


Real-time PCR detection of human herpesvirus 1-5 in patients lacking clinical signs of a viral CNS infection.

Sundén B, Larsson M, Falkeborn T, Paues J, Forsum U, Lindh M, Ydrenius L, Akerlind B, Serrander L.

BMC Infect Dis. 2011 Aug 17;11:220. doi: 10.1186/1471-2334-11-220.

Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk